Silence Therapeutics plc

OTCPK:SLNC.F Stock Report

Market Cap: US$983.5m

Silence Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SLNC.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies620,9451.34%
Hedge Funds3,879,1738.34%
VC/PE Firms6,295,35013.5%
Individual Insiders11,446,53924.6%
Institutions11,659,83425.1%
General Public12,600,43127.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.3%.


Top Shareholders

Top 25 shareholders own 72.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
Richard Griffiths
7,282,796US$154.0m-18.7%no data
8.81%
Robert Keith
4,096,766US$86.6m0%no data
8.34%
Lombard Odier Asset Management (USA) Corp
3,879,173US$82.0m0%8.89%
7.77%
Lombard Odier Asset Management (Europe) Ltd.
3,612,877US$76.4m0%1.15%
7.09%
TCG Crossover Management, LLC
3,295,350US$69.7m56.6%5.96%
6.45%
Artal Group S.A.
3,000,000US$63.5m0%1.78%
4.2%
Deep Track Capital, LP
1,951,580US$41.3m0%1.33%
3.24%
BVF Partners L.P.
1,508,416US$31.9m0%0.76%
2.24%
Aquilo Capital Management, LLC
1,043,284US$22.1m-20.5%13.74%
1.89%
Frazier Life Sciences Management, LP
881,173US$18.6m0%0.85%
1.33%
Sarossa Plc
620,238US$13.1m0%no data
1.1%
Vivo Capital, LLC
510,204US$10.8m0%0.81%
0.86%
Logos Global Management, L.P.
400,000US$8.5m0%0.94%
0.78%
M28 Capital Management LP
363,800US$7.7m0%5.72%
0.51%
Lynx1 Capital Management LP
235,787US$5.0m0%1.3%
0.5%
Parkman Healthcare Partners LLC
232,942US$4.9m20.8%0.66%
0.38%
HSBC Global Asset Management (UK) Limited
177,834US$3.8m0%no data
0.32%
Cantor Fitzgerald Asset Management
146,777US$3.1m-12.7%0.08%
0.2%
UBS O'Connor LLC
93,198US$2.0m-5.22%0.17%
0.15%
UBS Asset Management AG
69,946US$1.5m1.21%no data
0.14%
Morgan Stanley, Investment Banking and Brokerage Investments
62,808US$1.3m17.9%no data
0.13%
Citigroup Inc.,Banking and Securities Investments
58,333US$1.2m0%no data
0.11%
U.S. Global Investors, Inc.
53,197US$1.1m0%0.05%
0.11%
Ariad Asset Management Gmbh
50,000US$1.1m0%0.77%
0.11%
Woodline Partners LP
49,272US$1.0m-70.4%0.01%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.